messag turn solid perform ep yoy
beat revenu organ came street
call downbeat howev manag highlight one-tim
item boost number loss distribut agreement like
weigh result result view anoth step right
direct read-through state turnaround effort littl less posit
headlin may suggest pt move
follow result updat estim beyond
model call adjust ep yoy total revenu
cc compar prior estim respect
forecast ep sale cc
outlook includ top-lin headwind loss bone cement distribut
contract longer term see zimmer top line grower
current product portfolio potenti leverag gain bottom line
margin recov current depress level compani pay debt
believ growth excess level requir compani begin execut
next phase turnaround plan name upgrad portfolio rais averag growth
rate market particip zimmer balanc sheet remain rel
constrain today cash balanc sheet debt/ebitda ratio still
compani begin flexibl pursu potenti move
final lower price target take
account recent multipl compress across group revis estim
sector medic suppli devic
page analyst certif import disclosur
zimmer merger biomet made player hip knee wide
margin share global recon sale deal provid compani
ep accret scale also left zimmer sale come slow growth
market underperform late under-perform
exacerb past two year chronic manufactur issu suppli
constraint leav zimmer unabl servic client base effect recent remedi
effort begun address issu posit compani drive
improv top line growth profit move long-term continu
see opportun addit valu creation commit shed non-
core asset diversifi higher growth adjac think strateg shift
would view posit street result higher multipl stock
today trade signific discount rest large-cap med-tech group
zimmer share current trade ntm ep estim ntm
ebitda well large-cap med-tech averag view
discount broader group justifi given zimmer inferior top line growth trajectori
vs see current valuat gap excess expect share
re-rat upward market discount possibl new manag drive
growth reacceler lower price target
base multipl previous revis forward ntm ep
estim signific upsid potenti target current level assign
zimmer share buy rate
downsid risk rate includ failur attract talent new leadership and/or
implement strateg shift drive sustain valu creation increas price and/or
volum pressur ortho implant manufactur bundl payment initi
greater anticip share loss recon due linger suppli constraint
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
figur annual revenu build pro forma bmet deal jan
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
